Our analysis conclusively reported MKK3 oncogenic functions in melanoma, prostate, and colon cancer (Table 1), while oncosuppressive functions were identified in glioblastoma and gastric cancer (Table 1). The gene discussed is MAP2K3; the disease is gastric cancer.